Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells (Q38290626)

1 September 2017

Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells (English)

1 reference

1 September 2017

vaccinia virus

1 reference

Janilyn Arsenio

1

1 reference

1 September 2017

Yvon Deschambault

series ordinal

2

1 reference

1 September 2017

Jingxin Cao

series ordinal

3

1 reference

1 September 2017

language of work or name

English

0 references

publication date

27 May 2008

1 reference

1 September 2017

1 reference

1 September 2017

377

1 reference

1 September 2017

124-132

1 reference

1 September 2017

1

1 reference

Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model

1 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Host-range restriction of vaccinia virus E3L-specific deletion mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Activation of RNase L by 2',5'-oligoadenylates. Kinetic characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

IFNs and STATs in innate immunity to microorganisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Are all type I human interferons equivalent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Interferon-induced Mx proteins in antiviral host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Viruses, endoplasmic reticulum stress, and interferon responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Inhibition of PKR by RNA and DNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Biological activity of interleukins-28 and -29: comparison with type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Interferons, interferon-like cytokines, and their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Interferon treatment inhibits early events in vaccinia virus gene expression in infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Poxviruses and immune evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

How cells respond to interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Growth inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

7 January 2021

The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

7 January 2021

Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

7 January 2021

Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

7 January 2021

Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.04.014

7 January 2021

10.1016/J.VIROL.2008.04.014

Identifiers

DOI

1 reference

1 September 2017

1 reference